Adenosarcoma of the uterus: Clinical Trials

2 trials for Adenosarcoma of the uterus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow Adenosarcoma of the uterus: new trials by email Literature Review of Adenosarcoma of the uterus trials Research Report on Adenosarcoma of the uterus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Elacestrant - Uterine Sarcoma, Uterine Leiomyosarcoma
Phase 2RecruitingDana-Farber Cancer Institute302026-03-252026-05-22
FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study
Fulvestrant - Endometrial Stromal Sarcoma, Adenosarcoma of Uterus
Phase 2CompletedFrederic Amant172019-03-132024-05-28

Narrower conditions

Sarcoma, Endometrial Stromal (2)  ·  Endometrial Neoplasms (1)  ·  Perivascular Epithelioid Cell Neoplasms (1)  ·  Sex Cord-Gonadal Stromal Tumors (1)

Broader conditions

Endometrial Stromal Tumors (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Complex and Mixed (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Sarcoma (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Uterine Diseases (2)  ·  Uterine Neoplasms (2)

Interventions

Fulvestrant (1)  ·  RAD1901 (1)  ·  elacestrant (1)

Sponsors

Dana-Farber Cancer Institute (1)  ·  Frederic Amant (1)

Countries

Belgium (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Suzanne George, MD (1)

NIH funding

2017 (1)